HR Execs on the Move

Beebe Medical Center

www.beebemed.org

 
Beebe Medical Center, founded in 1916, is a not-for-profit community medical center governed by a volunteer Board of Trustees. Beebe has become the premier healthcare facility in Sussex County, serving a thriving beach and vacation resort area and a growing year-round population. Beebe provides comprehensive inpatient, outpatient, emergency, and home care in medical-surgical, obstetrics, pediatrics, oncology, and critical-care medicine. Outpatient services include an Outpatient Surgical Center, Diagnostic Imaging Centers, and Rehabilitation. Beebe Medical Center serves as a teaching facility for many regional allied health and professional education programs. Clinical practicums/experience are available in all continuums of care. Beebe Medical Center ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details

Similar Companies

Good Shepherd Geriatric Ctr

Good Shepherd Geriatric Ctr is a Mason City, IA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Blood Assurance

Blood Assurance is a Chattanooga, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Canadian Dermatology Association

Canadian Dermatology Association is a Ottawa, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

CorEMR

CorEMR is a Midway, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Relmada

Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.